Literature DB >> 15664382

Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors.

Gilles Pagès1, Jacques Pouysségur.   

Abstract

The vascular endothelial growth factor A (VEGF-A) is essential during embryonic development as inactivation of only one allele of its gene results in embryonic lethality. Up-regulation of VEGF under physiological situations allows for adaptation to hypoxic stress, to transient inflammatory processes, and to wounding. Its expression also increases all along the process of neovascularization of solid and hematological tumors. The object of this article is to focus on the transcriptional regulation of its gene. The major cis-acting sequences and trans-activating factors will be described as well as the physiological and pathological situations leading to the intervention of such sequences and factors. We will also focus on two transcription factors essential to VEGF gene transcription: the hypoxia-inducible factor-1, which is responsible for its increased by hypoxia, as well as Sp1, which is implicated in the response to various extracellular stimuli.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664382     DOI: 10.1016/j.cardiores.2004.09.032

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  163 in total

1.  PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling.

Authors:  Peter Noy; Hannah Williams; Anyaporn Sawasdichai; Kevin Gaston; Padma-Sheela Jayaraman
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

Review 2.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

3.  Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis.

Authors:  Dirk Schmidt; Björn Textor; Oliver T Pein; Alexander H Licht; Sven Andrecht; Melanie Sator-Schmitt; Norbert E Fusenig; Peter Angel; Marina Schorpp-Kistner
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

4.  Essential role of B-Raf in ERK activation during extraembryonic development.

Authors:  Gergana Galabova-Kovacs; Dana Matzen; Daniela Piazzolla; Katrin Meissl; Tatiana Plyushch; Adele P Chen; Alcino Silva; Manuela Baccarini
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

5.  Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin.

Authors:  Nadia Cherradi; Cyrille Lejczak; Agnes Desroches-Castan; Jean-Jacques Feige
Journal:  Mol Endocrinol       Date:  2005-11-23

6.  SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

Authors:  Melanie L Hart; Iris C Gorzolla; Jens Schittenhelm; Simon C Robson; Holger K Eltzschig
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

7.  Central role of Sp1-regulated CD39 in hypoxia/ischemia protection.

Authors:  Holger K Eltzschig; David Köhler; Tobias Eckle; Tianqing Kong; Simon C Robson; Sean P Colgan
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

8.  Molecular imaging of expression of vascular endothelial growth factor a (VEGF a) in femoral bone grafts transplanted into living mice.

Authors:  Olga Strachna; Daniel Torrecilla; Marie K Reumann; Inna Serganova; Jihye Kim; Simone Gieschler; Adele L Boskey; Ronald G Blasberg; Philipp Mayer-Kuckuk
Journal:  Cell Transplant       Date:  2013-04-12       Impact factor: 4.064

9.  The VEGF IRESes are differentially susceptible to translation inhibition by miR-16.

Authors:  Zeïneb S Karaa; Jason S Iacovoni; Amandine Bastide; Eric Lacazette; Christian Touriol; Hervé Prats
Journal:  RNA       Date:  2009-02       Impact factor: 4.942

10.  Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.

Authors:  Takeru Yoshimura; Koh-hei Sonoda; Mika Sugahara; Yasutaka Mochizuki; Hiroshi Enaida; Yuji Oshima; Akifumi Ueno; Yasuaki Hata; Hiroki Yoshida; Tatsuro Ishibashi
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.